Journal article
44P BOLD-100-001: A phase II study of BOLD-100 in combination with FOLFOX in advanced mCRC patients that have failed at least two prior lines of therapy
Authors
O'Kane GM; Spratlin J; Oh D-Y; Rha SY; McWhirter E; Elimova E; Kavan P; Choi MK; Kim D; Goodwin RA
Journal
Annals of Oncology, Vol. 35, ,
Publisher
Elsevier
Publication Date
June 1, 2024
DOI
10.1016/j.annonc.2024.05.055
ISSN
0923-7534